Morbid obesity and type 2 diabetes are both important public health problems. Obesity is an important risk factor for type 2 diabetes. 90% of type 2 diabetics worldwide are overweight. Insulin resistance is the main problem in the metabolic syndrome that leads to type 2 diabetes. Decreased insulin sensitivity and impaired beta cell function are the cause of type 2 diabetes, and insulin resistance is the link between obesity and type 2 DM. The formation of type diabetes with obesity is not only associated with the degree of obesity, but also the distribution of fat accumulation plays an important role, since the increased amount of fat around the abdomen is closely related to type 2 diabetes and heart disease.
Bariatric surgery has proven effective in treating obesity and type 2 diabetes. Obesity surgery has high efficiency in long-term treatment of type 2 diabetes and provides sustainable weight loss.
Surgeries that correct type 2 diabetes are known among the people as sugar surgery.
Since 2001, the mini-gastric bypass, an anastomotic gastric bypass, has been described as an effective alternative to RYGB in the management of morbid obesity and type 2 diabetes.
In 2011, the International Diabetes Federation reported that the method to be chosen during type 2 diabetes treatment should be "simple" and "reversible". These two options are also available in mini gastric bypass.
The mini-gastric bypass seems to be a promising option for the treatment of type 2 diabetes in obese and non-obese patients, although there is not much evidence in the literature at the moment.
Due to the good weight loss after mini gastric bypass surgery and rapid recovery from type 2 diabetes, it is becoming a more and more popular method of metabolic surgery day by day.
Mini Gastric Bypass is a sugar surgery that is popular today because it is a method with low complication rates, it is easy to use, long-term weight control is very good, long-term sugar control is better than gastric sleeve surgery and equal to RNY bypass.
Long-term follow-up of patients shows that there is no great need for external vitamin and protein support.
+90 532 466 67 67